Clinical trials
Observational Fatty Liver trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Recruiting | 3 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Oxford | 2 |
| Hywel Dda Health Board | 1 |
| Imperial College London | 1 |
| Institute of Cancer Research, United Kingdom | 1 |
| King's College Hospital NHS Trust | 1 |
| King's College London | 1 |
| Newcastle University | 1 |
| Protara Therapeutics | 1 |
| Richmond Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fatty Liver | 10 |
| Non-alcoholic Fatty Liver Disease | 5 |
| Liver Cirrhosis | 4 |
| Obesity | 3 |
| Cardiovascular Diseases | 2 |
| Carcinoma, Hepatocellular | 1 |
| Cholestasis | 1 |
| Choline Deficiency | 1 |
| Cognitive Dysfunction | 1 |
| Diabetes Mellitus, Type 2 | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.